
Next Generation Sequencing Market - forecast to 2033 : By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Ti
Description
Next Generation Sequencing Market - forecast to 2033 : By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), BY APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), PRODUCT (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), WORKFLOW (NGS Library Preparation Kits, Semi-automated Library Preparation, Automated Library Preparation, Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Tertiary Data Analysis), and Region
Next Generation Sequencing (NGS) is a revolutionary technology that has transformed the field of genomics and beyond. It refers to non-Sanger-based high-throughput DNA sequencing technologies. More than a million DNA strands can be sequenced in parallel, providing massive amounts of data and revolutionizing genomic research.
The Next Generation Sequencing Market Market size was USD 8.3 Billion in 2023, and it is anticipated to grow to over 56.2 Billion by 2033, at a CAGR of over 21% during the forecast period.
NGS, also known as high-throughput sequencing, has revolutionized the field of genomics by enabling researchers to sequence, re-sequence, and perform whole-genome sequencing rapidly and cost-effectively. This technology has dramatically reduced sequencing costs, making it feasible to sequence large amounts of DNA, such as a complete human genome, in a relatively short time. The NGS market is characterized by its wide range of applications across various fields, including oncology, clinical investigation, reproductive health, agrigenomics, and consumer genomics. Its high growth potential is driven by continuous technological advancements, expanding applications, and the decreasing cost of sequencing. Key applications driving the NGS market include disease diagnosis by identifying genetic mutations, drug discovery through insights into the genetic basis of diseases, personalized medicine development based on individual genetic profiles, and agricultural research for improving crop varieties through genomic insights.
Key Trends:
- Precision Medicine: The rise of personalized treatment plans based on individual genetic makeup is driving demand for next-generation sequencing technologies.
- Non-Invasive Prenatal Testing: Next-generation sequencing is increasingly being used for non-invasive prenatal testing, providing safer and more accurate results than traditional methods.
- Cancer Genomics: Next-generation sequencing is playing a crucial role in cancer genomics, helping to identify genetic mutations and enabling targeted therapy.
- Direct-to-Consumer Genetic Testing: The popularity of home-based genetic testing kits is on the rise, opening up a new market for next-generation sequencing technologies.
- Data Storage and Management: The vast amount of data generated by next-generation sequencing is driving the need for advanced data storage and management solutions.
- Technological Advancements: Rapid advancements in NGS technology, including improvements in data accuracy and speed, are driving its adoption in various applications.
- Increasing Genomic Research: The growing interest in genomic research for understanding genetic variations in diseases is fueling the demand for NGS.
- Declining Cost of Sequencing: The falling cost of genome sequencing is making NGS more accessible to researchers and clinicians, thereby driving market growth.
- Rise in Personalized Medicine: The increasing focus on personalized medicine for providing tailored medical treatment to individual patients is propelling the demand for NGS.
- Growing Clinical Applications: The expanding applications of NGS in clinical diagnosis, especially in cancer and inherited genetic disorder testing, are boosting the market growth.
- High Costs: The high costs associated with next-generation sequencing technologies can be a significant barrier to entry, especially for smaller labs and research institutions.
- Lack of Skilled Professionals: The complexity of next-generation sequencing requires a high level of expertise. The shortage of skilled professionals in this field can limit market growth.
- Regulatory Challenges: The next-generation sequencing market faces stringent regulatory guidelines and requirements, which can slow down the approval and adoption of new technologies.
- Data Storage and Management: The massive amount of data generated by next-generation sequencing presents significant challenges in terms of storage, management, and interpretation.
- Ethical and Privacy Concerns: The potential for misuse of genetic information can raise ethical and privacy concerns, which can hinder the acceptance and growth of the next-generation sequencing market.
Type (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), Application (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics And Epidemiology, Consumer Genomics, Agricultural & Animal Research), End-User (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), Product (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), Workflow (NGS Library Preparation Kits, Semi-Automated Library Preparation, Automated Library Preparation, Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Tertiary Data Analysis), And Region
Key Players:
The Next Generation Sequencing Market includes players such as Illumina, Thermo Fisher Scientific, Pacific Biosciences, Agilent Technologies, BGI Genomics, Bio-Rad Laboratories, F. Hoffmann-La Roche, Oxford Nanopore Technologies, Qiagen, 10x Genomics, Eurofins Scientific, Macrogen, PerkinElmer, Novogene, Takara Bio, Twist Bioscience, Integrated DNA Technologies, Nugen Technologies, and Zymo Research, among others.
Value Chain Analysis:
The value chain analysis for the Next Generation Sequencing Market can be delineated into five critical stages: Raw Material Procurement, Research and Development (R&D), Product Approval, Large-Scale Manufacturing, and Sales and Marketing. Each stage is integral to the overall success and efficiency of the market operations. Below is an in-depth exploration of each stage in the value chain analysis for the Next Generation Sequencing Market.
- Raw Material Procurement: Identify and secure sources of raw materials, such as high-quality reagents, nucleotides, and sequencing kits, which are essential for next-generation sequencing. Assess the availability, quality, and sustainability of these materials to ensure a consistent supply. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial to maintaining cost-effectiveness and reliability.
- Research and Development (R&D): Focus on conducting comprehensive market analysis and trend forecasting to identify emerging needs and opportunities within the next-generation sequencing market. Engage in feasibility studies and rigorous experimental protocols to develop innovative sequencing technologies or improve existing methodologies. Collaborate with academic institutions, research organizations, and industry experts to stay at the forefront of technological advancements and scientific discoveries.
- Product Approval: Navigate the complex landscape of legal requirements, industry regulations, and certification processes to obtain necessary approvals for new sequencing products. This involves rigorous testing for safety, efficacy, and environmental impact, ensuring compliance with regulatory standards set by bodies such as the FDA, EMA, and other relevant authorities. Establishing robust quality assurance protocols and documentation is essential to facilitate smooth approval processes.
- Large-Scale Manufacturing: Optimize production processes to enhance efficiency, reduce costs, and maintain high-quality standards. Implement advanced process engineering techniques, automation technologies, and effective supply chain management strategies to scale up manufacturing operations. Continuous monitoring and improvement of production workflows are vital to meet the increasing demand for next-generation sequencing products while ensuring consistency and reliability.
- Sales and Marketing: Develop a deep understanding of customer needs, market trends, and the competitive landscape to craft effective sales and marketing strategies. Conduct market segmentation, consumer behavior analysis, and branding initiatives to position next-generation sequencing products effectively. Leverage digital marketing, strategic partnerships, and targeted outreach to engage potential customers, drive adoption, and build brand loyalty. Emphasize the unique value propositions and competitive advantages of the products to differentiate them in the market.
- Estimates and forecast the overall market size for the total market, across type, application, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
350 Pages
- 1.0: MARKET DEFINITION
- 1.1: MARKET SEGMENTATION
- 1.2: MARKET SEGMENTATION
- 1.3: REGIONAL COVERAGE
- 1.4: KEY COMPANY PROFILES
- 1.5: DATA SNAPSHOT
- 2.0: SUMMARY
- 2.1: KEY OPINION LEADERS
- 2.2: KEY HIGHLIGHTS BY TYPE
- 2.3: KEY HIGHLIGHTS BY TECHNOLOGY
- 2.4: KEY HIGHLIGHTS BY BY APPLICATION
- 2.5: KEY HIGHLIGHTS BY END-USER
- 2.6: KEY HIGHLIGHTS BY PRODUCT
- 2.7: KEY HIGHLIGHTS BY WORKFLOW
- 2.8: KEY HIGHLIGHTS BY REGION
- 2.9: KEY HIGHLIGHTS BY NORTH AMERICA
- 2.10: KEY HIGHLIGHTS BY LATIN AMERICA
- 2.11: KEY HIGHLIGHTS BY EUROPE
- 2.12: KEY HIGHLIGHTS BY ASIA/PACIFIC
- 2.13: KEY HIGHLIGHTS BY MIDDLE EAST/AFRICA
- 3.0: MARKET ATTRACTIVENESS ANALYSIS BY TYPE
- 3.1: MARKET ATTRACTIVENESS ANALYSIS BY TECHNOLOGY
- 3.2: MARKET ATTRACTIVENESS ANALYSIS BY BY APPLICATION
- 3.3: MARKET ATTRACTIVENESS ANALYSIS BY END-USER
- 3.4: MARKET ATTRACTIVENESS ANALYSIS BY PRODUCT
- 3.5: MARKET ATTRACTIVENESS ANALYSIS BY WORKFLOW
- 3.6: MARKET ATTRACTIVENESS ANALYSIS BY REGION
- 3.7: MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
- 4.0: MARKET TRENDS
- 4.1: MARKET DRIVERS
- 4.2: MARKET OPPORTUNITIES
- 4.3: MARKET RESTRAINTS
- 4.4: MARKET THREATS
- 4.5: IMPACT ANALYSIS
- 5.0: PORTERS FIVE FORCES
- 5.1: ANSOFF MATRIX
- 5.2: PESTLE ANALYSIS
- 5.3: VALUE CHAIN ANALYSIS
- 6.0: IMPACT OF COVID-19 ON MARKET
- 7.0: IMPACT OF RUSSIA-UKRAINE WAR
- 8.0: PARENT MARKET ANALYSIS
- 8.1: REGULATORY LANDSCAPE
- 8.2: PRICING ANALYSIS
- 8.3: DEMAND SUPPLY ANALYSIS
- 8.4: DEMAND SUPPLY ANALYSIS
- 8.5: CONSUMER BUYING INTEREST
- 8.6: CONSUMER BUYING INTEREST
- 8.7: SUPPLY CHAIN ANALYSIS
- 8.8: COMPETITION PRODUCT ANALYSIS BY MANUFACTURER
- 8.9: TECHNOLOGICAL ADVANCEMENTS
- 8.10: RECENT DEVELOPMENTS
- 8.11: CASE STUDIES
- 9.0: MARKET SIZE AND FORECAST – BY VALUE (US$ MILLION)
- 9.1: MARKET SIZE AND FORECAST – BY VOLUME (UNITS)
- 10.0: TYPE OVERVIEW
- 10.1: MARKET SIZE AND FORECAST – BY TYPE
- 10.2: RNA SEQUENCING OVERVIEW
- 10.3: RNA SEQUENCING BY REGION
- 10.4: RNA SEQUENCING BY COUNTRY
- 10.5: WHOLE GENOME SEQUENCING OVERVIEW
- 10.6: WHOLE GENOME SEQUENCING BY REGION
- 10.7: WHOLE GENOME SEQUENCING BY COUNTRY
- 10.8: EXOME SEQUENCING OVERVIEW
- 10.9: EXOME SEQUENCING BY REGION
- 10.10: EXOME SEQUENCING BY COUNTRY
- 10.11: TARGETED SEQUENCING OVERVIEW
- 10.12: TARGETED SEQUENCING BY REGION
- 10.13: TARGETED SEQUENCING BY COUNTRY
- 10.14: DE NOVO SEQUENCING OVERVIEW
- 10.15: DE NOVO SEQUENCING BY REGION
- 10.16: DE NOVO SEQUENCING BY COUNTRY
- 11.0: TECHNOLOGY OVERVIEW
- 11.1: MARKET SIZE AND FORECAST – BY TECHNOLOGY
- 11.2: SEQUENCING BY SYNTHESIS OVERVIEW
- 11.3: SEQUENCING BY SYNTHESIS BY REGION
- 11.4: SEQUENCING BY SYNTHESIS BY COUNTRY
- 11.5: ION SEMICONDUCTOR SEQUENCING OVERVIEW
- 11.6: ION SEMICONDUCTOR SEQUENCING BY REGION
- 11.7: ION SEMICONDUCTOR SEQUENCING BY COUNTRY
- 11.8: SINGLE-MOLECULE REAL-TIME SEQUENCING OVERVIEW
- 11.9: SINGLE-MOLECULE REAL-TIME SEQUENCING BY REGION
- 11.10: SINGLE-MOLECULE REAL-TIME SEQUENCING BY COUNTRY
- 11.11: NANOPORE SEQUENCING OVERVIEW
- 11.12: NANOPORE SEQUENCING BY REGION
- 11.13: NANOPORE SEQUENCING BY COUNTRY
- 11.14: OTHER TECHNOLOGIES OVERVIEW
- 11.15: OTHER TECHNOLOGIES BY REGION
- 11.16: OTHER TECHNOLOGIES BY COUNTRY
- 12.0: BY APPLICATION OVERVIEW
- 12.1: MARKET SIZE AND FORECAST – BY BY APPLICATION
- 12.2: DIAGNOSTICS OVERVIEW
- 12.3: DIAGNOSTICS BY REGION
- 12.4: DIAGNOSTICS BY COUNTRY
- 12.5: ONCOLOGY OVERVIEW
- 12.6: ONCOLOGY BY REGION
- 12.7: ONCOLOGY BY COUNTRY
- 12.8: RESEARCH APPLICATIONS OVERVIEW
- 12.9: RESEARCH APPLICATIONS BY REGION
- 12.10: RESEARCH APPLICATIONS BY COUNTRY
- 12.11: CLINICAL INVESTIGATION OVERVIEW
- 12.12: CLINICAL INVESTIGATION BY REGION
- 12.13: CLINICAL INVESTIGATION BY COUNTRY
- 12.14: REPRODUCTIVE HEALTH OVERVIEW
- 12.15: REPRODUCTIVE HEALTH BY REGION
- 12.16: REPRODUCTIVE HEALTH BY COUNTRY
- 12.17: DRUG DISCOVERY OVERVIEW
- 12.18: DRUG DISCOVERY BY REGION
- 12.19: DRUG DISCOVERY BY COUNTRY
- 12.20: HLA TYPING/IMMUNE SYSTEM MONITORING OVERVIEW
- 12.21: HLA TYPING/IMMUNE SYSTEM MONITORING BY REGION
- 12.22: HLA TYPING/IMMUNE SYSTEM MONITORING BY COUNTRY
- 12.23: METAGENOMICS AND EPIDEMIOLOGY OVERVIEW
- 12.24: METAGENOMICS AND EPIDEMIOLOGY BY REGION
- 12.25: METAGENOMICS AND EPIDEMIOLOGY BY COUNTRY
- 12.26: CONSUMER GENOMICS OVERVIEW
- 12.27: CONSUMER GENOMICS BY REGION
- 12.28: CONSUMER GENOMICS BY COUNTRY
- 12.29: AGRICULTURAL & ANIMAL RESEARCH OVERVIEW
- 12.30: AGRICULTURAL & ANIMAL RESEARCH BY REGION
- 12.31: AGRICULTURAL & ANIMAL RESEARCH BY COUNTRY
- 13.0: END-USER OVERVIEW
- 13.1: MARKET SIZE AND FORECAST – BY END-USER
- 13.2: ACADEMIC & RESEARCH INSTITUTIONS OVERVIEW
- 13.3: ACADEMIC & RESEARCH INSTITUTIONS BY REGION
- 13.4: ACADEMIC & RESEARCH INSTITUTIONS BY COUNTRY
- 13.5: BIOPHARMACEUTICAL & BIOTECHNOLOGY OVERVIEW
- 13.6: BIOPHARMACEUTICAL & BIOTECHNOLOGY BY REGION
- 13.7: BIOPHARMACEUTICAL & BIOTECHNOLOGY BY COUNTRY
- 13.8: HOSPITALS & CLINICS OVERVIEW
- 13.9: HOSPITALS & CLINICS BY REGION
- 13.10: HOSPITALS & CLINICS BY COUNTRY
- 13.11: CONTRACT RESEARCH ORGANIZATIONS OVERVIEW
- 13.12: CONTRACT RESEARCH ORGANIZATIONS BY REGION
- 13.13: CONTRACT RESEARCH ORGANIZATIONS BY COUNTRY
- 13.14: DIAGNOSTIC LABORATORIES OVERVIEW
- 13.15: DIAGNOSTIC LABORATORIES BY REGION
- 13.16: DIAGNOSTIC LABORATORIES BY COUNTRY
- 13.17: FORENSIC LABS OVERVIEW
- 13.18: FORENSIC LABS BY REGION
- 13.19: FORENSIC LABS BY COUNTRY
- 13.20: AGRICULTURAL RESEARCH CENTERS OVERVIEW
- 13.21: AGRICULTURAL RESEARCH CENTERS BY REGION
- 13.22: AGRICULTURAL RESEARCH CENTERS BY COUNTRY
- 13.23: GOVERNMENT & REGULATORY AGENCIES OVERVIEW
- 13.24: GOVERNMENT & REGULATORY AGENCIES BY REGION
- 13.25: GOVERNMENT & REGULATORY AGENCIES BY COUNTRY
- 14.0: PRODUCT OVERVIEW
- 14.1: MARKET SIZE AND FORECAST – BY PRODUCT
- 14.2: SEQUENCING OVERVIEW
- 14.3: SEQUENCING BY REGION
- 14.4: SEQUENCING BY COUNTRY
- 14.5: DATA ANALYSIS OVERVIEW
- 14.6: DATA ANALYSIS BY REGION
- 14.7: DATA ANALYSIS BY COUNTRY
- 14.8: SAMPLE PREPARATION OVERVIEW
- 14.9: SAMPLE PREPARATION BY REGION
- 14.10: SAMPLE PREPARATION BY COUNTRY
- 14.11: TARGET ENRICHMENT OVERVIEW
- 14.12: TARGET ENRICHMENT BY REGION
- 14.13: TARGET ENRICHMENT BY COUNTRY
- 14.14: OTHERS OVERVIEW
- 14.15: OTHERS BY REGION
- 14.16: OTHERS BY COUNTRY
- 15.0: WORKFLOW OVERVIEW
- 15.1: MARKET SIZE AND FORECAST – BY WORKFLOW
- 15.2: NGS LIBRARY PREPARATION KITS OVERVIEW
- 15.3: NGS LIBRARY PREPARATION KITS BY REGION
- 15.4: NGS LIBRARY PREPARATION KITS BY COUNTRY
- 15.5: SEMI-AUTOMATED LIBRARY PREPARATION OVERVIEW
- 15.6: SEMI-AUTOMATED LIBRARY PREPARATION BY REGION
- 15.7: SEMI-AUTOMATED LIBRARY PREPARATION BY COUNTRY
- 15.8: AUTOMATED LIBRARY PREPARATION OVERVIEW
- 15.9: AUTOMATED LIBRARY PREPARATION BY REGION
- 15.10: AUTOMATED LIBRARY PREPARATION BY COUNTRY
- 15.11: SEQUENCING OVERVIEW
- 15.12: SEQUENCING BY REGION
- 15.13: SEQUENCING BY COUNTRY
- 15.14: NGS PRIMARY DATA ANALYSIS OVERVIEW
- 15.15: NGS PRIMARY DATA ANALYSIS BY REGION
- 15.16: NGS PRIMARY DATA ANALYSIS BY COUNTRY
- 15.17: NGS SECONDARY DATA ANALYSIS OVERVIEW
- 15.18: NGS SECONDARY DATA ANALYSIS BY REGION
- 15.19: NGS SECONDARY DATA ANALYSIS BY COUNTRY
- 15.20: NGS TERTIARY DATA ANALYSIS OVERVIEW
- 15.21: NGS TERTIARY DATA ANALYSIS BY REGION
- 15.22: NGS TERTIARY DATA ANALYSIS BY COUNTRY
- 15.23: OVERVIEW
- 15.24: REGION OVERVIEW
- 15.25: MARKET SIZE AND FORECAST - BY REGION
- 15.26: NORTH AMERICA OVERVIEW
- 15.27: NORTH AMERICA BY COUNTRY
- 15.28: UNITED STATES OVERVIEW
- 15.29: UNITED STATES OVERVIEW
- 15.30: UNITED STATES OVERVIEW
- 15.31: UNITED STATES OVERVIEW
- 15.32: UNITED STATES OVERVIEW
- 15.33: UNITED STATES OVERVIEW
- 15.34: UNITED STATES OVERVIEW
- 15.35: LOCAL MARKET ANALYSIS - UNITED STATES
- 15.36: CANADA OVERVIEW
- 15.37: CANADA OVERVIEW
- 15.38: CANADA OVERVIEW
- 15.39: CANADA OVERVIEW
- 15.40: CANADA OVERVIEW
- 15.41: CANADA OVERVIEW
- 15.42: CANADA OVERVIEW
- 15.43: LOCAL MARKET ANALYSIS - CANADA
- 15.44: LATIN AMERICA OVERVIEW
- 15.45: LATIN AMERICA BY COUNTRY
- 15.46: MEXICO OVERVIEW
- 15.47: MEXICO OVERVIEW
- 15.48: MEXICO OVERVIEW
- 15.49: MEXICO OVERVIEW
- 15.50: MEXICO OVERVIEW
- 15.51: MEXICO OVERVIEW
- 15.52: MEXICO OVERVIEW
- 15.53: LOCAL MARKET ANALYSIS - MEXICO
- 15.54: BRAZIL OVERVIEW
- 15.55: BRAZIL OVERVIEW
- 15.56: BRAZIL OVERVIEW
- 15.57: BRAZIL OVERVIEW
- 15.58: BRAZIL OVERVIEW
- 15.59: BRAZIL OVERVIEW
- 15.60: BRAZIL OVERVIEW
- 15.61: LOCAL MARKET ANALYSIS - BRAZIL
- 15.62: ARGENTINA OVERVIEW
- 15.63: ARGENTINA OVERVIEW
- 15.64: ARGENTINA OVERVIEW
- 15.65: ARGENTINA OVERVIEW
- 15.66: ARGENTINA OVERVIEW
- 15.67: ARGENTINA OVERVIEW
- 15.68: ARGENTINA OVERVIEW
- 15.69: LOCAL MARKET ANALYSIS - ARGENTINA
- 15.70: REST OF LATAM OVERVIEW
- 15.71: REST OF LATAM OVERVIEW
- 15.72: REST OF LATAM OVERVIEW
- 15.73: REST OF LATAM OVERVIEW
- 15.74: REST OF LATAM OVERVIEW
- 15.75: REST OF LATAM OVERVIEW
- 15.76: REST OF LATAM OVERVIEW
- 15.77: LOCAL MARKET ANALYSIS - REST OF LATAM
- 15.78: EUROPE OVERVIEW
- 15.79: EUROPE BY COUNTRY
- 15.80: GERMANY OVERVIEW
- 15.81: GERMANY OVERVIEW
- 15.82: GERMANY OVERVIEW
- 15.83: GERMANY OVERVIEW
- 15.84: GERMANY OVERVIEW
- 15.85: GERMANY OVERVIEW
- 15.86: GERMANY OVERVIEW
- 15.87: LOCAL MARKET ANALYSIS - GERMANY
- 15.88: FRANCE OVERVIEW
- 15.89: FRANCE OVERVIEW
- 15.90: FRANCE OVERVIEW
- 15.91: FRANCE OVERVIEW
- 15.92: FRANCE OVERVIEW
- 15.93: FRANCE OVERVIEW
- 15.94: FRANCE OVERVIEW
- 15.95: LOCAL MARKET ANALYSIS - FRANCE
- 15.96: UNITED KINGDOM OVERVIEW
- 15.97: UNITED KINGDOM OVERVIEW
- 15.98: UNITED KINGDOM OVERVIEW
- 15.99: UNITED KINGDOM OVERVIEW
- 15.100: UNITED KINGDOM OVERVIEW
- 15.101: UNITED KINGDOM OVERVIEW
- 15.102: UNITED KINGDOM OVERVIEW
- 15.103: LOCAL MARKET ANALYSIS - UNITED KINGDOM
- 15.104: RUSSIA OVERVIEW
- 15.105: RUSSIA OVERVIEW
- 15.106: RUSSIA OVERVIEW
- 15.107: RUSSIA OVERVIEW
- 15.108: RUSSIA OVERVIEW
- 15.109: RUSSIA OVERVIEW
- 15.110: RUSSIA OVERVIEW
- 15.111: LOCAL MARKET ANALYSIS - RUSSIA
- 15.112: SPAIN OVERVIEW
- 15.113: SPAIN OVERVIEW
- 15.114: SPAIN OVERVIEW
- 15.115: SPAIN OVERVIEW
- 15.116: SPAIN OVERVIEW
- 15.117: SPAIN OVERVIEW
- 15.118: SPAIN OVERVIEW
- 15.119: LOCAL MARKET ANALYSIS - SPAIN
- 15.120: ITALY OVERVIEW
- 15.121: ITALY OVERVIEW
- 15.122: ITALY OVERVIEW
- 15.123: ITALY OVERVIEW
- 15.124: ITALY OVERVIEW
- 15.125: ITALY OVERVIEW
- 15.126: ITALY OVERVIEW
- 15.127: LOCAL MARKET ANALYSIS - ITALY
- 15.128: NETHERLANDS OVERVIEW
- 15.129: NETHERLANDS OVERVIEW
- 15.130: NETHERLANDS OVERVIEW
- 15.131: NETHERLANDS OVERVIEW
- 15.132: NETHERLANDS OVERVIEW
- 15.133: NETHERLANDS OVERVIEW
- 15.134: NETHERLANDS OVERVIEW
- 15.135: LOCAL MARKET ANALYSIS - NETHERLANDS
- 15.136: ISRAEL OVERVIEW
- 15.137: ISRAEL OVERVIEW
- 15.138: ISRAEL OVERVIEW
- 15.139: ISRAEL OVERVIEW
- 15.140: ISRAEL OVERVIEW
- 15.141: ISRAEL OVERVIEW
- 15.142: ISRAEL OVERVIEW
- 15.143: LOCAL MARKET ANALYSIS - ISRAEL
- 15.144: TURKEY OVERVIEW
- 15.145: TURKEY OVERVIEW
- 15.146: TURKEY OVERVIEW
- 15.147: TURKEY OVERVIEW
- 15.148: TURKEY OVERVIEW
- 15.149: TURKEY OVERVIEW
- 15.150: TURKEY OVERVIEW
- 15.151: LOCAL MARKET ANALYSIS - TURKEY
- 15.152: REST OF EUROPE OVERVIEW
- 15.153: REST OF EUROPE OVERVIEW
- 15.154: REST OF EUROPE OVERVIEW
- 15.155: REST OF EUROPE OVERVIEW
- 15.156: REST OF EUROPE OVERVIEW
- 15.157: REST OF EUROPE OVERVIEW
- 15.158: REST OF EUROPE OVERVIEW
- 15.159: LOCAL MARKET ANALYSIS - REST OF EUROPE
- 15.160: ASIA/PACIFIC OVERVIEW
- 15.161: ASIA/PACIFIC BY COUNTRY
- 15.162: CHINA OVERVIEW
- 15.163: CHINA OVERVIEW
- 15.164: CHINA OVERVIEW
- 15.165: CHINA OVERVIEW
- 15.166: CHINA OVERVIEW
- 15.167: CHINA OVERVIEW
- 15.168: CHINA OVERVIEW
- 15.169: LOCAL MARKET ANALYSIS - CHINA
- 15.170: INDIA OVERVIEW
- 15.171: INDIA OVERVIEW
- 15.172: INDIA OVERVIEW
- 15.173: INDIA OVERVIEW
- 15.174: INDIA OVERVIEW
- 15.175: INDIA OVERVIEW
- 15.176: INDIA OVERVIEW
- 15.177: LOCAL MARKET ANALYSIS - INDIA
- 15.178: JAPAN OVERVIEW
- 15.179: JAPAN OVERVIEW
- 15.180: JAPAN OVERVIEW
- 15.181: JAPAN OVERVIEW
- 15.182: JAPAN OVERVIEW
- 15.183: JAPAN OVERVIEW
- 15.184: JAPAN OVERVIEW
- 15.185: LOCAL MARKET ANALYSIS - JAPAN
- 15.186: AUSTRALIA OVERVIEW
- 15.187: AUSTRALIA OVERVIEW
- 15.188: AUSTRALIA OVERVIEW
- 15.189: AUSTRALIA OVERVIEW
- 15.190: AUSTRALIA OVERVIEW
- 15.191: AUSTRALIA OVERVIEW
- 15.192: AUSTRALIA OVERVIEW
- 15.193: LOCAL MARKET ANALYSIS - AUSTRALIA
- 15.194: INDONESIA OVERVIEW
- 15.195: INDONESIA OVERVIEW
- 15.196: INDONESIA OVERVIEW
- 15.197: INDONESIA OVERVIEW
- 15.198: INDONESIA OVERVIEW
- 15.199: INDONESIA OVERVIEW
- 15.200: INDONESIA OVERVIEW
- 15.201: LOCAL MARKET ANALYSIS - INDONESIA
- 15.202: MALAYSIA OVERVIEW
- 15.203: MALAYSIA OVERVIEW
- 15.204: MALAYSIA OVERVIEW
- 15.205: MALAYSIA OVERVIEW
- 15.206: MALAYSIA OVERVIEW
- 15.207: MALAYSIA OVERVIEW
- 15.208: MALAYSIA OVERVIEW
- 15.209: LOCAL MARKET ANALYSIS - MALAYSIA
- 15.210: REST OF APAC OVERVIEW
- 15.211: REST OF APAC OVERVIEW
- 15.212: REST OF APAC OVERVIEW
- 15.213: REST OF APAC OVERVIEW
- 15.214: REST OF APAC OVERVIEW
- 15.215: REST OF APAC OVERVIEW
- 15.216: REST OF APAC OVERVIEW
- 15.217: LOCAL MARKET ANALYSIS - REST OF APAC
- 15.218: MIDDLE EAST/AFRICA OVERVIEW
- 15.219: MIDDLE EAST/AFRICA BY COUNTRY
- 15.220: SAUDI ARABIA OVERVIEW
- 15.221: SAUDI ARABIA OVERVIEW
- 15.222: SAUDI ARABIA OVERVIEW
- 15.223: SAUDI ARABIA OVERVIEW
- 15.224: SAUDI ARABIA OVERVIEW
- 15.225: SAUDI ARABIA OVERVIEW
- 15.226: SAUDI ARABIA OVERVIEW
- 15.227: LOCAL MARKET ANALYSIS - SAUDI ARABIA
- 15.228: UAE OVERVIEW
- 15.229: UAE OVERVIEW
- 15.230: UAE OVERVIEW
- 15.231: UAE OVERVIEW
- 15.232: UAE OVERVIEW
- 15.233: UAE OVERVIEW
- 15.234: UAE OVERVIEW
- 15.235: LOCAL MARKET ANALYSIS - UAE
- 15.236: SOUTH AFRICA OVERVIEW
- 15.237: SOUTH AFRICA OVERVIEW
- 15.238: SOUTH AFRICA OVERVIEW
- 15.239: SOUTH AFRICA OVERVIEW
- 15.240: SOUTH AFRICA OVERVIEW
- 15.241: SOUTH AFRICA OVERVIEW
- 15.242: SOUTH AFRICA OVERVIEW
- 15.243: LOCAL MARKET ANALYSIS - SOUTH AFRICA
- 15.244: IRAN OVERVIEW
- 15.245: IRAN OVERVIEW
- 15.246: IRAN OVERVIEW
- 15.247: IRAN OVERVIEW
- 15.248: IRAN OVERVIEW
- 15.249: IRAN OVERVIEW
- 15.250: IRAN OVERVIEW
- 15.251: LOCAL MARKET ANALYSIS - IRAN
- 15.252: QATAR OVERVIEW
- 15.253: QATAR OVERVIEW
- 15.254: QATAR OVERVIEW
- 15.255: QATAR OVERVIEW
- 15.256: QATAR OVERVIEW
- 15.257: QATAR OVERVIEW
- 15.258: QATAR OVERVIEW
- 15.259: LOCAL MARKET ANALYSIS - QATAR
- 15.260: REST OF MEA OVERVIEW
- 15.261: REST OF MEA OVERVIEW
- 15.262: REST OF MEA OVERVIEW
- 15.263: REST OF MEA OVERVIEW
- 15.264: REST OF MEA OVERVIEW
- 15.265: REST OF MEA OVERVIEW
- 15.266: REST OF MEA OVERVIEW
- 15.267: LOCAL MARKET ANALYSIS - REST OF MEA
- 15.268: COMPETITION OVERVIEW
- 15.269: MARKET SHARE ANALYSIS
- 15.270: MARKET REVENUE BY KEY COMPANIES
- 15.271: MARKET POSITIONING
- 15.272: VENDORS BENCHMARKING
- 15.273: STRATEGY BENCHMARKING
- 15.274: STRATEGY BENCHMARKING
- 15.275: Illumina
- 15.276: Illumina
- 15.277: Illumina
- 15.278: Illumina
- 15.279: Illumina
- 15.280: Thermo Fisher Scientific
- 15.281: Thermo Fisher Scientific
- 15.282: Thermo Fisher Scientific
- 15.283: Thermo Fisher Scientific
- 15.284: Thermo Fisher Scientific
- 15.285: Pacific Biosciences
- 15.286: Pacific Biosciences
- 15.287: Pacific Biosciences
- 15.288: Pacific Biosciences
- 15.289: Pacific Biosciences
- 15.290: Agilent Technologies
- 15.291: Agilent Technologies
- 15.292: Agilent Technologies
- 15.293: Agilent Technologies
- 15.294: Agilent Technologies
- 15.295: BGI Genomics
- 15.296: BGI Genomics
- 15.297: BGI Genomics
- 15.298: BGI Genomics
- 15.299: BGI Genomics
- 15.300: Bio-Rad Laboratories
- 15.301: Bio-Rad Laboratories
- 15.302: Bio-Rad Laboratories
- 15.303: Bio-Rad Laboratories
- 15.304: Bio-Rad Laboratories
- 15.305: F. Hoffmann-La Roche
- 15.306: F. Hoffmann-La Roche
- 15.307: F. Hoffmann-La Roche
- 15.308: F. Hoffmann-La Roche
- 15.309: F. Hoffmann-La Roche
- 15.310: Oxford Nanopore Technologies
- 15.311: Oxford Nanopore Technologies
- 15.312: Oxford Nanopore Technologies
- 15.313: Oxford Nanopore Technologies
- 15.314: Oxford Nanopore Technologies
- 15.315: Qiagen
- 15.316: Qiagen
- 15.317: Qiagen
- 15.318: Qiagen
- 15.319: Qiagen
- 15.320: 10x Genomics
- 15.321: 10x Genomics
- 15.322: 10x Genomics
- 15.323: 10x Genomics
- 15.324: 10x Genomics
- 15.325: Genewiz
- 15.326: Genewiz
- 15.327: Genewiz
- 15.328: Genewiz
- 15.329: Genewiz
- 15.330: Eurofins Scientific
- 15.331: Eurofins Scientific
- 15.332: Eurofins Scientific
- 15.333: Eurofins Scientific
- 15.334: Eurofins Scientific
- 15.335: Macrogen
- 15.336: Macrogen
- 15.337: Macrogen
- 15.338: Macrogen
- 15.339: Macrogen
- 15.340: PerkinElmer
- 15.341: PerkinElmer
- 15.342: PerkinElmer
- 15.343: PerkinElmer
- 15.344: PerkinElmer
- 15.345: Novogene
- 15.346: Novogene
- 15.347: Novogene
- 15.348: Novogene
- 15.349: Novogene
- 15.350: Takara Bio
- 15.351: Takara Bio
- 15.352: Takara Bio
- 15.353: Takara Bio
- 15.354: Takara Bio
- 15.355: Twist Bioscience
- 15.356: Twist Bioscience
- 15.357: Twist Bioscience
- 15.358: Twist Bioscience
- 15.359: Twist Bioscience
- 15.360: Integrated DNA Technologies
- 15.361: Integrated DNA Technologies
- 15.362: Integrated DNA Technologies
- 15.363: Integrated DNA Technologies
- 15.364: Integrated DNA Technologies
- 15.365: Nugen Technologies
- 15.366: Nugen Technologies
- 15.367: Nugen Technologies
- 15.368: Nugen Technologies
- 15.369: Nugen Technologies
- 15.370: Zymo Research
- 15.371: Zymo Research
- 15.372: Zymo Research
- 15.373: Zymo Research
- 15.374: Zymo Research
- 561})
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.